Article PDF
Avoid common mistakes on your manuscript.
References
Folkers KM, Bateman-House A. Improving expanded access in the United States: the role of the institutional review board. Therapeutic Innovation & Regulatory Science. 2018;52(3):285–293.
Wendler T, Mongiello F, McLinn J, Bellina M. Right to Try Act of 2017. https://www.congress.gov/bill/115th-congress/senate-bill/204/test. Accessed July 28, 2018.
IRB services, expanded access. https://www.wirb.com/Pages/IRBServices.aspx. Accessed May 11, 2018.
Expanded access to investigational drugs for treatment use—questions and answers, guidance for industry. Food and Drug Administration. https://www.fda.gov/downloads/drugs/guidances/ucm351261.pdf. Published June 2016. Updated October 2017. Accessed May 11, 2018.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Klein, R., Speers, M.A. Value of IRB in Expanded Access. Ther Innov Regul Sci 52, 689 (2018). https://doi.org/10.1177/2168479018797969
Published:
Issue Date:
DOI: https://doi.org/10.1177/2168479018797969